Literature DB >> 2734981

Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

J J König1, E Kamst, A Hagemeijer, J C Romijn, J Horoszewicz, F H Schröder.   

Abstract

The cytogenetic evolution of the prostatic adenocarcinoma cell line LNCaP was investigated during long term in vitro culture. Study of five different sublines demonstrated that the original karyotype was well preserved in all sublines, with respect to the chromosome number as well as to the primary markers. All sublines showed additional, subline specific secondary marker chromosomes. Comparison of these markers in androgen responsive and nonresponsive sublines showed rearrangement of the short arm of chromosome 8 in both unresponsive sublines. The breakpoints were in 8p21 and 8p23, respectively, resulting in deletion of the 8p23----pter region in both sublines. In contrast, the hormone responsive sublines did not show any aberrations in chromosome 8. Review of published karyotypes of patients and cell lines seems to support our finding of partial deletion of 8p in androgen unresponsive prostate tumor cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734981     DOI: 10.1007/bf00262025

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  33 in total

1.  Growth in semisolid agar of prostate cancer cells obtained from bone marrow aspirates.

Authors:  F R Ahmann; L Woo; M Hendrix; J M Trent
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

2.  Chromosomal locations of human tissue plasminogen activator and urokinase genes.

Authors:  B Rajput; S F Degen; E Reich; E K Waller; J Axelrod; R L Eddy; T B Shows
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

3.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

4.  Restricted number of chromosomal regions implicated in aetiology of human cancer and leukaemia.

Authors:  F Mitelman
Journal:  Nature       Date:  1984 Jul 26-Aug 1       Impact factor: 49.962

5.  Chromosome rearrangements in a metastatic adenocarcinoma of the prostate.

Authors:  Z Gibas; J E Pontes; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1985-04-15

6.  Testosterone metabolism by cytochrome P-450 isozymes RLM3 and RLM5 and by microsomes. Metabolite identification.

Authors:  K C Cheng; J B Schenkman
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

7.  Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro.

Authors:  S H Bigner; J Mark; D D Bigner
Journal:  Cancer Genet Cytogenet       Date:  1987-01

8.  Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia.

Authors:  A H Parmiter; G Balaban; W H Clark; P C Nowell
Journal:  Cancer Genet Cytogenet       Date:  1988-02

9.  Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82).

Authors:  J J König; A Hagemeijer; B Smit; E Kamst; J C Romijn; F H Schröder
Journal:  Cancer Genet Cytogenet       Date:  1988-08

10.  Nonreciprocal chromosome translocation t(5;14) in cancers of the kidney: adenocarcinoma of the renal parenchyma and transitional cell carcinoma of the kidney pelvis.

Authors:  F Hecht; C S Berger; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1985-01-15
View more
  6 in total

Review 1.  The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.

Authors:  G J van Steenbrugge; M Groen; J W van Dongen; J Bolt; H van der Korput; J Trapman; M Hasenson; J Horoszewicz
Journal:  Urol Res       Date:  1989

2.  LNCaP-OM, a new androgen-resistant prostate cancer subline.

Authors:  M Platica; R S Verma; M J Macera; O Platica
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

3.  Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.

Authors:  X Zhao; G J van Steenbrugge; F H Schröder
Journal:  Urol Res       Date:  1992

Review 4.  Review of allelic loss and gain in prostate cancer.

Authors:  G S Bova; W B Isaacs
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 5.  The Genomics of Prostate Cancer: A Historic Perspective.

Authors:  Mark A Rubin; Francesca Demichelis
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

6.  Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.

Authors:  Z Culig; J Hoffmann; M Erdel; I E Eder; A Hobisch; A Hittmair; G Bartsch; G Utermann; M R Schneider; K Parczyk; H Klocker
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.